Skip to content

ZENIM: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ZENIM

BE 0825.646.875
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€75,772
2024 · €67,921+€7,851
Equity
€102,275
2024 · €26,502+€75,772
Cash
€33,554
2024 · €11,160+€22,394
Balance sheet total
€224,171
2024 · €200,875+€23,296

Largest movements

2024 to 2025
Assets
  • Cash +€22,394

    up €22,394 (+201%), from €11,160 to €33,554

    mainly Net result for the year (+€75,772) and Depreciation (+€21,724)

  • Receivables within one year +€20,423

    up €20,423 (+207%), from €9,866 to €30,289

    of which Other amounts receivable: +€19,135

  • Tangible fixed assets -€20,029

    down €20,029 (-11.2%), from €179,447 to €159,418

    of which Plant, machinery and equipment: -€10,359

Equity and liabilities
  • Profit (loss) carried forward +€75,772

    up €75,772, from -€358 to €75,415

  • Other debts -€72,253

    down €72,253 (-84.3%), from €85,722 to €13,468

  • Tax, wage and social debts +€15,808

    up €15,808 (+41.8%), from €37,797 to €53,605

  • Trade debts +€3,992

    up €3,992 (+7.9%), from €50,831 to €54,823

Income statement
  • Taxes -€9,767

    down €9,767 (-48.5%), from €20,154 to €10,386

  • Other operating charges -€6,247

    down €6,247 (-29.3%), from €21,290 to €15,043

  • Gross operating margin -€4,596

    down €4,596 (-3.5%), from €129,785 to €125,189

  • Depreciation +€3,807

    up €3,807 (+21.2%), from €17,917 to €21,724

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €67,921
Gross operating margin -€4,596
Depreciation -€3,807
Other operating charges +€6,247
Financial income -€7
Financial charges +€247
Taxes +€9,767
Result 2025 €75,772
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€24,089
Investment -€1,695
Financing €0
Cash 2024 €11,160
Net result for the year +€75,772
Depreciation +€21,724
Receivables within one year -€20,423
Deferred charges and accrued income -€508
Trade debts +€3,992
Tax, wage and social debts +€15,808
Other debts -€72,253
Accrued charges and deferred income -€23
Investment in fixed assets (net) -€1,695
Cash 2025 €33,554
brings cash intakes cash out
Every line side by side 39 lines
Line Code 2024 2025 Change %
Total assets 20/58 €200,875 €224,171 +€23,296 +11.6%
Fixed assets 21/28 €179,447 €159,418 -€20,029 -11.2%
Tangible fixed assets 22/27 €179,447 €159,418 -€20,029 -11.2%
Land and buildings 22 €138,700 €133,000 -€5,700 -4.1%
Plant, machinery and equipment 23 €36,213 €25,854 -€10,359 -28.6%
Furniture and vehicles 24 €4,534 €564 -€3,970 -87.6%
Current assets 29/58 €21,428 €64,754 +€43,325 +202%
Amounts receivable within one year 40/41 €9,866 €30,289 +€20,423 +207%
Trade receivables 40 €9,865 €11,152 +€1,288 +13.1%
Other amounts receivable 41 €1 €19,137 +€19,135 +1,386,629%
Cash at bank and in hand 54/58 €11,160 €33,554 +€22,394 +201%
Deferred charges and accrued income 490/1 €402 €910 +€508 +126%
Total equity and liabilities 10/49 €200,875 €224,171 +€23,296 +11.6%
Equity 10/15 €26,502 €102,275 +€75,772 +286%
Contributions 10/11 €25,000 €25,000 = 0.0%
Reserves 13 €1,860 €1,860 = 0.0%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Profit (loss) carried forward 14 -€358 €75,415 +€75,772
Amounts payable 17/49 €174,373 €121,897 -€52,476 -30.1%
Amounts payable within one year 42/48 €174,350 €121,897 -€52,453 -30.1%
Trade debts 44 €50,831 €54,823 +€3,992 +7.9%
Suppliers 440/4 €50,831 €54,823 +€3,992 +7.9%
Taxes, remuneration and social security 45 €37,797 €53,605 +€15,808 +41.8%
Taxes 450/3 €37,797 €53,605 +€15,808 +41.8%
Other amounts payable 47/48 €85,722 €13,468 -€72,253 -84.3%
Accrued charges and deferred income 492/3 €23 - -€23
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €17,917 €21,724 +€3,807 +21.2%
Other operating charges 640/8 €21,290 €15,043 -€6,247 -29.3%
Gross operating margin 9900 €129,785 €125,189 -€4,596 -3.5%
Operating profit (loss) 9901 €90,578 €88,422 -€2,156 -2.4%
Financial income 75/76B €8 €1 -€7 -87.0%
Recurring financial income 75 €8 €1 -€7 -87.0%
Financial charges 65/66B €2,511 €2,264 -€247 -9.8%
Recurring financial charges 65 €2,511 €2,264 -€247 -9.8%
Profit (loss) for the period before taxes 9903 €88,075 €86,159 -€1,916 -2.2%
Income taxes 67/77 €20,154 €10,386 -€9,767 -48.5%
Profit (loss) for the period 9904 €67,921 €75,772 +€7,851 +11.6%
Profit (loss) for the period to be appropriated 9905 €67,921 €75,772 +€7,851 +11.6%

Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.